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ABSTRACT 
MITCH D. VANBRUGGEN: The Relationship between Plasma and Salivary Cortisol 
Levels in Response to Different Exercise Intensities 
(Under the direction of Anthony C. Hackney, Ph.D., D.Sc.) 
 
This study examined the effect of exercise intensity on the serum and salivary cortisol 
responses of endurance-trained males.  Subjects (n = 12) rested for 30 minutes (control) and  
exercised for 30 minutes at 40%, 60%, or 80% of VO2 max on separate days.  Serum and saliva 
samples were collected pre-trial, post-trial, and 30 minutes post-recovery.  The overall 
correlation between serum and saliva in all matched pairs was significant (r = 0.548; p< 
0.005).  Cortisol responses increased significantly with both measures in response to exercise 
(p < 0.05).  However, exercise peak serum responses occurred at the post-trial time while 
saliva peaked at the post-recovery time. The highest correlations between serum-saliva at 
individual sampling times were during post-recovery.  Findings suggest that salivary cortisol 
sampling may be a useful technique in some circumstances if confounding factors are 
considered and controlled. 
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CHAPTER I 
 
BASIS FOR STUDY 
 
Introduction 
 Cortisol levels increase in response to psychological and physical stressors such as 
life changes, extreme temperatures, negative energy balance, and physical exercise 
(McMurray & Hackney, 2000; Viru et al., 2004).  In response to the stress of exercise, 
cortisol has many specific functions helping the body modify and adapt to the stress, 
including: the mobilization of free fatty acids (FFA) from adipose tissue, protein catabolism, 
stimulation of gluconeogenesis at the liver, and inhibition of glucose uptake by the working 
skeletal muscle (Brooks et al., 2000).  These responses act to increase exercise capacity and 
aid in recovery and adaptation (Viru et al., 2007). 
 When stressed, the hypothalamus secretes corticotrophin releasing hormone (CRH), 
which activates the anterior pituitary and stimulates the release of adrenocorticotropin 
hormone (ACTH).  The presence of ACTH stimulates the adrenal cortex to release cortisol 
(Neal, 2001).   Cortisol secretion is controlled through a negative feedback process, where 
high levels inhibit the secretion of ACTH from the anterior pituitary.  In contrast, high levels 
of ACTH and cortisol can signal the hypothalamus to reduce the secretion of CRH.  This 
entire interconnected process is referred to as the hypothalamic-pituitary-adrenocortical 
(HPA) axis (Hill et al., 2008). 
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Most previous exercise studies investing cortisol responses to exercise are in 
agreement that there is a ―threshold intensity‖ that results in significant elevations in 
circulating cortisol. For example, Davies and colleagues (1973) found that an exercise 
intensity of 50-60% of VO2max must be reached for cortisol to be increased and the absolute 
levels attained during exercise are dependent on the total duration of the exercise bout.  In 
another example, Hill and colleagues (2008) examined the effect of exercise intensity upon 
the cortisol response of the HPA axis in moderately trained men.  Moderate to high intensity 
(60% and 80% of maximal oxygen consumption [VO2 max]) exercise augmented circulating 
cortisol levels.  These increases were a result of a combination of hemoconcentration and 
HPA axis stimulus (ACTH).  Conversely, low intensity exercise (40% of VO2 max) did not 
result in significant increases in cortisol levels, actually reducing cortisol concentrations 
when accounting for plasma volume changes (Hill et al., 2008).   
While there are similar findings in previous research assessing cortisol release and 
circulation during exercise, many of these studies measured the cortisol response by 
assessing concentrations in the serum of the blood.  While this method is accurate and 
consistent, collection of blood samples is invasive, difficult to obtain during the exercise 
process, and can also augment the stress response of the subject due to the collection 
procedure (Kirschbaum et al., 1994). 
Cortisol concentrations measured in saliva may provide a feasible, accurate, and 
practical alternative to serum determinations. In fact, some laboratories, clinicians, and 
neuroendocrine researchers already use this technique (Hellhammer et al., 2009).  Since 
cortisol is a lipophilic steroid with low molecular weight, the cortisol that is unbound to 
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carrier proteins (e.g. cortisol binding globulin [CBG]) can enter the cells through passive 
diffusion.  In this way, it is possible to measure these free cortisol levels in all bodily fluids, 
including saliva.  Since only a small, unbound fraction of the hormone is available to diffuse 
into the saliva, concentrations are consistently lower than in serum. However, it has been 
demonstrated that salivary cortisol levels have a steady and predictable relation to the free, 
unbound cortisol levels in serum and salivary levels accurately reflect serum levels regardless 
of the degree of stimulation of the saliva glands (Vining et al., 1983).  Previous studies have 
found correlation coefficients between cortisol in saliva and cortisol in serum ranging from r 
= 0.71 to r = 0.96 (Kirschbaum et al., 1994). However, these cross-sectional correlations 
reflect associations between the two methods when subjects were at rest—exercise studies 
were not included in the review. 
Though many studies consider salivary cortisol concentrations a reliable and accurate 
measure of this hormone, there is still some controversy surrounding this technique.  Due to 
the passive movement of cortisol from the serum into the saliva, there may be a delayed 
response in salivary concentrations accurately reflecting the response in the blood (Umeda et 
al., 1981).  Additionally, because the response of the HPA axis is controlled through many 
processes and factors, cortisol levels in the saliva may be partly disassociated from the other 
processes regulating the HPA feedback loop, including ACTH and CRH.  Moreover, 
previous studies comparing methodologies have not used exercise as the stressor to stimulate 
the HPA axis (Hellhammer et al., 2009). The acute stress of short exercise bouts (compared 
to prolonged exercise) may not allow for sufficient time for cortisol to diffuse into saliva. 
Thus, this methodology needed to be further explored, particularly in response to extreme 
stressors, such as physical exercise.  
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Purpose 
 This purpose of this study was to investigate the associations between serum and 
salivary cortisol levels pre-trial, immediate post-trial and after recovery (30 minutes; post-
recovery) at three different intensities (40%, 60%, and 80% of VO2 max) and a control trial to 
determine if salivary concentrations could be an accurate method to assess the body‘s stress 
response to exercise. It also aimed to determine if there was a similar temporal relationship 
for peak responses to exercise. 
 
Research hypotheses 
1. There will be significant correlations between serum and salivary cortisol concentrations at 
the pre-trial, post-trial and post-recovery sampling time within each of the experimental trials 
(control, 40%, 60% and 80% VO2 max exercise). 
2.  The peak saliva cortisol response when compared to the peak serum response within the 
60% and 80% exercise trials will occur at a later sampling time. 
 
Definition of terms 
Adrenocorticotropic hormone (ACTH) –a polypeptide tropic hormone produced and secreted 
by the anterior pituitary gland (Neal, 2001). 
Cortisol – A glucocorticoid hormone secreted from the zona fasciculata of the adrenal cortex. 
Cortisol release is stimulated by adrenocorticotropin hormone (ACTH) from the anterior 
pituitary (Neal, 2001). 
Cortisol binding globulin (CBG) –a large plasma protein that the majority of cortisol is 
bound to as it travels in the blood (Kirschbaum et al., 1994). 
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Corticotropin releasing hormone (CRH) – a hormone secreted by the paraventricular nucleus 
(PVN) of the hypothalmus in response to stress (Neal, 2001).   
Hypothalamic-pituitary-adrenocortical (HPA) axis – an interconnected feedback loop which 
is a major part of the neuroendocrine system that controls reactions to stress and regulates 
many of the body‘s processes.  
Maximal oxygen uptake (VO2 max) – the maximum capacity to transport and utilize oxygen 
during whole-body exercise (Brooks et al., 2000). 
Radioimmunoassay (RIA) – a highly sensitive laboratory technique that analyzes of the 
binding between an antigen and its homologous antibody in order to identify and quantify a 
substance (e.g. hormone) in a biological fluid (Chard, 1990). 
Salivary cortisol enzyme immunoassay (EIA) – a highly sensitive immunochemical test in 
which cortisol in standards and unknowns compete with cortisol linked to horseradish 
peroxidase for the antibody binding sites. The amount of cortisol peroxidase detected is 
inversely proportional to the amount of cortisol present (Chard, 1990). 
 
Delimitations 
1. Subjects were healthy, endurance-trained males between 18 and 30 years of age. 
2. Subjects reported to each trial 4 hours post-prandial, and maintained and controlled their 
diet preceding each of the experimental trials. 
3. Experimental trials were completed in random order, separated by at least 72 hours. 
4.  Each of the experimental trials were conducted at the same time of day (within each 
subject) to account for circadian rhythms. 
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5. Psychological stress was controlled for as each subject demonstrated normal scores on the 
Recovery-Stress Questionnaire (REST-Q) before proceeding with each of the separate 
experimental trials.  
 
Limitations 
1. The results can only be generalized to the sample studied:  healthy, moderately to highly 
endurance trained adult males between 18 and 30 years of age. 
2. The sample size in this study was relatively small (n = 12) due to limitations in recruiting 
moderate to highly trained males. 
 
Significance of study 
 This study attempted to validate salivary cortisol as a reliable method to assess levels 
of this hormone in response to exercise.  Collection of saliva (as opposed to blood) facilities 
more frequent sampling, is less invasive, and allows subjects to obtain samples without the 
assistance of a phlebotomy technician. This permits sampling outside of a laboratory 
environment such as during a training session or competitive event.  This study is novel 
because it involved assessing each of these methods in response to different exercise 
intensities and determined if there was a delay in the peak responses of saliva compared to 
serum, which has not been extensively studied in previous research.  If this relationship 
between these two methods is better understood, it may facilitate saliva sampling as a more 
readily acceptable measurement in sports physiology. 
 
 
  
 
 
 
CHAPTER II 
 
REVIEW OF LITERATURE  
Introduction 
 It is important to note that there are few previous research studies which have 
specifically used salivary cortisol sampling techniques, especially in response to exercise 
protocols utilizing multiple intensities and in comparison to serum sampling techniques. This 
makes the purpose of this research study somewhat novel; however, it was also a limitation 
in that that there are few studies which provided an extensive groundwork and foundation to 
build upon and compare to in this project.   
 
Physiological mechanisms of cortisol release 
 Theory and overview  
 Cortisol secretion is controlled through the mechanisms of the hypothalamus, 
pituitary gland, and adrenal cortex (HPA axis).  In response to physiological and 
psychological stressors, the hypothalamus secretes corticotrophin-releasing hormone (CRH) 
which causes the anterior pituitary gland to secrete adrenocorticotropin releasing hormone 
(ACTH) into circulation.  This hormone then causes the adrenal cortex to release cortisol.  As 
the cortisol level is augmented, CRH and ACTH are inhibited through negative feedback 
(Brooks et al., 2000; McMurray & Hackney, 2000). 
 Cortisol release is stimulated by a wide array of stress-inducing stimuli, including 
exercise, which results in a wide array of mechanisms which help the body adapt to the stress 
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and return to homeostasis (Neal, 2001). The primary roles of cortisol include: proteolysis, 
stimulation of lipolysis, and promoting gluconeogenesis at the liver (Hackney, 2006; 
McMurray & Hackney, 2000).  Cortisol also prevents the uptake of glucose by the active 
skeletal muscle and has an inhibitory affect on protein synthesis during exercise and into the 
recovery period following an exercise bout.  Inhibition of protein synthesis in recovery 
functions to free amino acids into the blood which are used for muscle remodeling, to build 
new proteins, or to be shunted to the hepatic tissue to be used for substrate in 
gluconeogenesis. This is why cortisol levels often remain elevated for up to 120 minutes into 
recovery from the exercise bout (Viru et al., 2004). Figure 1 displays the control of the HPA 
axis and the effect of cortisol on the body‘s metabolic processes. 
 Factors influencing variability of responses  
 
 Acute exercise can result in increased cortisol levels, but the response of the hormone 
is largely dependent on the intensity of the exercise bout being completed.  The cortisol 
response during an acute exercise session is dependent on many other factors, including: 
circadian rhythms, environmental conditions, competitive nature of exercise bout, age, 
gender, genetics, anaerobiosis of the exercise, and nutritional considerations (Hackney, 2006; 
Thuma et al., 1995).    
 Training status is also a key component in cortisol responses- levels in trained 
subjects are generally more attenuated than those who are untrained or sedentary, even when 
the physically fit subjects work at the same percentage of their maximal capacity as the unfit 
subjects. Additionally, trained athletes typically have lesser responses as the duration of the 
exercise becomes longer and the effort becomes more difficult (Bloom et al., 1976).  This 
may be due to a higher number of receptors as well as an increased sensitivity to cortisol, 
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meaning that less of the hormone is needed to produce the responses required to adapt to the 
stress of the exercise (Powers & Howley, 2004). 
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Figure 1. Control of cortisol release in the hypothalamic-pituitary-adrenal (HPA) axis, 
highlighting the positive and negative feedback to the hypothalamus and cortisol‘s effects on 
the body‘s metabolic processes (adapted from Powers & Howley, 2004).  
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Serum cortisol sampling with exercise 
 
 Previous research studies which have analyzed subjects‘ cortisol responses to exercise 
have primarily utilized serum sampling to assess this hormone.  Daly and colleagues 
examined the cortisol responses to exhausting, prolonged exercise. Thirty-four healthy male 
subjects ran on a treadmill until volitional exhaustion. Blood specimens were analyzed for 
cortisol levels immediately at the end of exercise and at 30, 60, and 90 minutes into 
recovery. A significantly greater number of the peak cortisol responses occurred during the 
recovery period, indicating the importance of analyzing the cortisol responses into the 
recovery period and not simply before, during or immediately after the exercise session. 
(Daly et al., 2004). 
 Viru and colleagues also utilized serum sampling to assess cortisol responses to 
maximal exercise and how this was affected by adrenergic factors.  They had ten subjects run 
to exhaustion on a treadmill, and obtained blood samples pre-exercise and post exercise to be 
used to determine how the cortisol responses were affected by beta-adrenergic blockage as 
well as a competitive condition.  They found that both of these factors significantly 
augmented cortisol responses (n = 10; p < 0.05), but were not additive, suggesting that that 
there may be an upper limit on the magnitude of the of HPA response to intense exercise 
(Viru et al., 2007). 
 Davies and Few (1973) investigated the cortisol response of ten subjects to a light 
load (<50% VO2max) and a heavy load (60-90% VO2max). They determined that there needed 
to be a threshold intensity of approximately 60% VO2max in order for cortisol levels to 
increase.  Hill and colleagues (2008) also verified that a workload of at least 60% VO2max will 
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augment cortisol responses.  In this study, twelve moderately trained males exercised at 40%, 
60%, and 80% of VO2max.  Both the 60% and 80% trials resulted in significantly higher 
cortisol responses than during the resting (control) and 40% trial.  In fact, during the 40% 
exercise bout, there was a decrease in cortisol (Hill et al., 2008).  This is consistent with the 
explanation of Galbo (1983). Cortisol responses may appear to be decreasing in a subjects‘ 
serum, but this is just a turnover effect.  Cortisol is being released during the low intensity 
exercise, but the clearance rate is simply greater than what is being secreted, resulting in a 
lower concentration in the serum (Galbo, 1983). Other studies cited in review articles and 
textbook chapters have corroborated the intensity/threshold effect of cortisol, noting that 
approximately 60% of maximal aerobic capacity must be reached in order for cortisol levels 
to respond to the exercise (Brooks et al., 2000; McMurray & Hackney, 2000).   
 
Salivary cortisol methodology 
 Diffusive properties, sampling, and analysis 
 Control over saliva production is shared by the sympathetic and parasympathetic 
branches of the autonomic nervous system, which work together in an intricate, complex 
relationship. The parasympathetic system is largely responsible for enhancing fluid secretion 
by the salivary glands, with the sympathetic system playing a smaller role.  However, both of 
these systems can signal the myoepithelial cells in the salivary glands to contract, increasing 
the flow of saliva (Garrett, 1987). 
 Some compounds in the body can pass into the saliva from the blood, making saliva a 
viable and safe diagnostic fluid in many areas of scientific research, especially when 
compared to blood and urine (Kaufman et al., 2002).  Specifically, cortisol has a steady and 
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predictable relation to the free, unbound levels in serum. Salivary cortisol is a useful 
biomarker in stress research, as long as the researcher is aware of possible sources of 
variation, which may affect this measure. Several factors, including adrenal sensitivity and 
cortisol binding affect total and free cortisol levels in blood, translating to what 
concentrations are measured in the saliva (Hellhammer et al., 2009).  
 In a series of studies, Schwartz and colleagues evaluated the reliability of 
radioimmunoassay (RIA) for salivary cortisol.  They concluded that associations between 
serum and salivary cortisol were reliable and valid as long as contaminants were not 
introduced into the sampling process (Schwartz et al., 1998). Umeda and colleagues (1981) 
also examined the viability of salivary cortisol measurement, stating that it is an 
exceptionally accurate index of plasma free cortisol concentration, independently of salivary 
flow rate.  Additionally, Umeda maintained that this method may be preferable to other 
methods for many reasons: saliva is obtained by noninvasive stress-free procedures, is stable 
at room temperatures, is easier to collect, does not require skilled personnel for collection, 
and can be sample numerous times during a session in the laboratory or throughout the day at 
home or in the field (Levine et al., 2007). 
  
 Salivary cortisol sampling with exercise 
  
 Kivlighan and colleagues used saliva as the sampling method for obtaining cortisol 
responses to the anticipation of exercise as well as during the recovery period after the 
exercise. Though this study did not specifically focus on the methodology of the saliva 
sampling technique, it was unique in that the cortisol responses of the subjects were highly 
consistent with previous responses measured using serum concentrations.  That is, the 
13 
 
responses to the particular protocol of exercise and recovery mirrored cortisol concentrations 
measured via serum (Kivlighan et al., 2005).  However, this protocol utilized only one bout 
of exercise (2000 m rowing ergometer sprint) and did not measure responses to various 
exercise intensities, thus resulting in only one level of stress. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Saliva cortisol responses in trained and untrained men and women before 
competition, 20 minutes into recovery, and 40 minutes into recovery from the competitive 
exercise bout (adapted from Kivlighan et al., 2005). 
  
Jacks and colleagues also used saliva as a sampling technique in a study involving 
exercise and cortisol responses—however, this study measured responses to differences in 
exercise intensities.  Ten males were assigned to random, 1 hour-cycle ergometer bouts of 
exercise at approximately 40%, 60%, and 80% of their VO2 peak as well as a resting control 
session. The saliva samples were collected before exercise and then at 10, 20, 40, and 59 
minutes of exercise and at 20 minutes of recovery. They found that with the 80% exercise 
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intensity, cortisol was significantly higher at 59 minutes of exercise than at those same time 
points during the resting control session. No significant differences in cortisol concentration 
were found in the other exercise intensities (Jacks et al., 2002). This study was very similar 
in methodology to the present study, but utilized salivary sampling exclusively to determine 
the subjects‘ response to different exercise intensities and did not compare serum and 
sampling techniques and concentrations.   
 
Comparison of serum and saliva sampling 
 Previous studies have found strong relationships between the two sampling methods, 
evidenced by strong correlation coefficients between cortisol in saliva and cortisol in serum 
at rest ranging from r = 0.71 to r = 0.96 (Kirschbaum et al., 1994).  For instance, Vining and 
colleagues found that salivary cortisol concentrations were directly proportional  (p < 0.05) to 
the serum unbound cortisol concentration both in normal men and women and that the rate of 
equilibrium of cortisol between blood and saliva was very fast (less than 5 minutes).  
However, this investigation did not use exercise as the stressor to the HPA axis, which may 
have caused a slower equilibrium between free levels of the hormone in blood and saliva. 
Still, the researchers concluded that salivary cortisol is the more appropriate measure of the 
response of the HPA axis to stress than serum cortisol since it is more simple, stress free, and 
non-invasive (Vining et al., 1983).  Associations between the methods also remained high (r 
= 0.86; p < 0.05) when measuring cortisol with both methods throughout the circadian cycle 
of the hormone (Levine et al., 2007) 
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Comparisons of methods in response to exercise  
 Few studies have directly compared the two sampling techniques in response to 
exercise.  Ben-Aryeh and colleagues examined the effect of exercise on cortisol levels in 
serum and saliva in young, healthy males.  The subjects performed graded submaximal cycle 
exercise for nine min at up to 85% of their age-predicted maximal heart rate. Surprisingly, 
they found a non-significant increase in saliva and serum cortisol levels; however, the lack of 
significance was attributed to a decrease in blood flow in the salivary glands, dry mouth due 
to dehydration, and a decrease in measured salivary flow.  They also postulated that 
collection of the saliva samples later on during the recovery period would have yielded 
significant increases in cortisol concentrations as opposed to what was found immediately 
after the exercise session (Ben-Aryeh et al., 1989).  This study highlighted the importance of 
the timing of the serum and saliva sampling to limit other confounding variables that can 
affect the results of the cortisol responses in each of these fluids.  
 Thomasson and colleagues directly compared plasma and saliva hormones in 
response to exercise; however, the investigation focused on the hormones‘ response to a long 
exercise session (120 minutes) rather than a shorter, more intense bout.  Nine, healthy 
subjects exercised for the 120 minutes period at 50-55% of their VO2max. Blood and saliva 
samples were taken at rest and every 30 minutes during the exercise bout and found there 
was a significant relationship (r = 0.35; p <0.02) between the concentrations of cortisol in 
each of these biological fluids averaged over the exercise sessions.  They concluded that the 
non-invasive saliva sampling offers a realistic and practical approach in the measurement of 
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the response of the HPA axis to exercise and can be used as an alternative to serum sampling 
(Thomasson et al., 2009). 
 Research involving comparisons between serum and saliva using high intensity 
exercise have yielded mixed results immediately after exercise. Gonzansky and colleagues 
designed a study to determine whether salivary cortisol could be used instead of serum 
cortisol in across a broad range of concentrations. They found that the salivary cortisol 
responses to brief, intense exercise (90% of maximal heart rate for 10 minutes) paralleled 
serum cortisol (r = 0.60; p < 0.001).  The authors asserted that the salivary measures actually 
are advantageous compared to serum during intense exercise because serum concentrations 
are affected by the saturation point of cortisol binding globulin (CBG).  Therefore, using 
salivary cortisol as opposed to total serum cortisol eliminates the requirement to account for 
within-subject changes or between-subject differences in CBG (Gonzansky et al., 2005). 
Stupnicki and Obminski assessed serum and salivary cortisol concentrations in 78 elite 
athletes engaged in different sports, by subjecting them to high-intensity laboratory exercise. 
The mean difference in the pre-exercise cortisol concentrations in the seven groups studied 
were more marked in serum than in saliva. The correlations between the pre-exercise values 
were 0.47 for serum and 0.58 for saliva. This led the researchers to suggest that the salivary 
cortisol concentration might be a more suitable variable for assessing glucocorticoid activity 
before exercise and in response to exercise compared to serum cortisol concentrations since it 
is likely less sensitive to pre-exercise emotional state (Stupnicki & Obminski, 2002). 
 While concentrations measured immediately after exercise are useful when making 
comparisons between serum and saliva, there is limited research assessing responses into 
recovery from exercise. Neary and colleagues investigated the relationship among resting 
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cortisol levels measured in serum and saliva samples to determine which method would be 
the most appropriate and preferable to observe and monitor the physiological stress of 
exercise training. Serum and saliva samples were collected from eight subjects following one 
day of recovery from intense training. They found a significantly high correlation between 
serum and salivary cortisol (r = 0.99) and concluded that either sampling technique can be 
used to monitor cortisol during a recovery period from exercise training.  However, since the 
saliva collection is much less invasive, they maintained that it was the preferable method 
(Neary et al., 2002).    Finally, del Corral and colleagues assessed serum and salivary cortisol 
responses of young males during and after a 70% exercise session.  There were significant 
increases in cortisol responses to the exercise session with both methods. Additionally, the 
two methods were correlated (p < 0.05) after 30minutes of exercise (r = 0.90), and 15 min 
post-exercise (r = 0.84).  However, the levels were not correlated at rest (r = 0.46). This is 
one of the few studies which used both methods and assessed levels during recovery from 
exercise rather than simply immediately after exercise (del Corral et al., 1994).  However, 
responses were not assessed using multiple intensities as is design of the present study. 
 
Need for additional research on salivary cortisol in response to exercise 
 This study aimed to validate salivary cortisol sampling as a way to assess this stress 
related hormone in response to exercise intensity. While some previous studies have 
investigated salivary cortisol response to exercise, there is minimal research which has 
attempted to validate salivary cortisol responses to exercise using multiple intensities. The 
goal and unique aspect of this study was to examine if there is still a similar response in 
salivary concentrations to the established response in serum concentrations. With multiple 
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exercise intensities, it was necessary to investigate whether the relationships between these 
two methods are disassociated from one another, or if there was a mirrored relationship when 
comparing responses in serum and saliva.   Determining when the peak responses of cortisol 
occur in response to different exercise intensities using both methods may significantly 
contribute to the field of sports physiology. Since salivary methods are more practical and 
less invasive, future research may be possible in field settings, during training sessions, or 
before and after a competitive event. 
 
 
 
 
 
 
  
 
 
 
 
 
 CHAPTER III 
 
METHODOLOGY 
Subjects 
 Moderate to highly aerobically-trained male subjects (ages 18-30) were recruited 
from the campus of the University of North Carolina-Chapel Hill and surrounding areas for 
this study. Subjects must have trained consistently for a minimum of 3 days per week for 60 
minutes per day in the previous six months prior to the study. Each of the subjects were 
informed of the risks of the protocol, signed statement of informed consent, passed a medical 
and physical examination, and demonstrated normal scores on the Recovery Stress 
Questionnaire (REST-Q) prior to each experimental trial. If the subjects scored above the 
average of the midpoints of the stress scales, they were not allowed to proceed on that 
particular trial.  Exclusion criteria included: a diet chronically low (<50% of daily caloric 
consumption) in carbohydrates, a prior history of hormonal disorders, mental illness, or 
chronic non-steroidal anti-inflammatory (NSAID) drug use.  
 
Protocol 
  
 Each subject was asked to report to the Applied Physiology Laboratory at the 
University of North Carolina-Chapel Hill on five separate occasions. Subjects were 
instructed to maintain and control their diet (eucaloric and at least 50% of calories from 
carbohydrates) over the duration of the study.  Prior to when the subjects reported to the 
laboratory for the orientation session, they completed a 3-day diet record which they brought 
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with them to the laboratory.  In between the orientation session and the first experimental 
trial, the diet was analyzed using the nutrition database on the website of the United States 
Department of Agriculture to determine the macronutrient breakdown of their daily caloric 
intake.  If the subjects‘ diet did not meet the required average daily carbohydrate 
consumption to proceed, they were given guidance on how to healthily incorporate additional 
sources of this macronutrient into their diet.  After they completed another 3 day diet record 
and verified that their diet contained at least 50% of calories from carbohydrates, the subjects 
were allowed to continue with the experimental trials.  Furthermore, subjects were asked to 
come to laboratory 4 hours post-prandial, having consumed no caffeine or alcohol for 8 hours 
prior to the session. 
 
 Orientation Session 
VO2 max Test   Trial I              Trial II   Trial III   Trial IV 
 
  ~7 days  ~72 hrs ~72 hrs ~72 hrs 
 
 
 
 
Figure 3. Overview of experimental protocol. 
 
The first session served as both an orientation session and when the subjects‘ 
maximal oxygen uptake (VO2 max) was determined through an incremental exercise test on a 
cycle ergometer using 3 minute stages.  Following the initial meeting and VO2 max test, the 
next four experimental trials consisted of a control trial, and 30 minute cycling bouts at 40%, 
Trials were randomized and consisted of a 30 minute 
exercise trial at 40%, 60%, or 80% of subjects‘ VO2 max, or 
a 30 minute rest (control). 
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60%, and 80% of the subjects‘ VO2 max.  All of these trials were completed at the same time of 
day within each subjects‘ trials (± 30 minutes), were in a randomized order, and each trial 
was separated by a minimum of 72 hours. 
 
Orientation/maximal oxygen consumption (VO2 max) testing session  
 Subjects were instructed to refrain from any physical exercise for 24 hours before 
their VO2 max test.  Once subjects came to the laboratory, they were briefed on the protocol 
(exercise, blood collection procedures, metabolic monitoring) and were allowed to ask any 
questions about the procedure before signing the informed consent form.  Next, the subjects 
underwent a screening process, including a blood pressure reading, a 12-lead 
electrocardiogram, and a brief discussion on previous illnesses and family history of potential 
problems to ensure that they could safely participate in the study. After approval for 
participation, anthropometric data (age, height, weight, body fat percentage via skinfolds) 
were determined for each subject.  
 After subject characteristics were assessed, they were instructed to warm-up on the 
cycle ergometer for 5 minutes at a very light workload.  At this time, the seat height was 
adjusted to the optimal height and comfort. The light warm up was followed up by 5 minutes 
of stretching, primarily emphasizing the torso and the lower extremities. The subject was 
subsequently properly fit with a mouthpiece and oxygen uptake which was used to make sure 
that the values were normal and the metabolic system was functioning properly. 
 The incremental exercise test began at a workload previously determined by the 
subjects‘ training history and any previous VO2 max data results reported by the subject. The 
workload increased at the end of the 3 minute intervals (stages) until volitional fatigue.  
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Metabolic data was averaged over 15 second intervals, heart rate data was recorded every 
minute, and ratings of perceived exertion (RPE) were assessed at the end of each exercise 
stage.  The test was considered valid and reliable if the subjects met three out of the four 
criteria: a 150 ml/min or less increase in VO2 in response to an increased workload;  HR at 
the age predicted maximum (within 5%); a respiratory exchange ratio (RER) of 1.1 or 
greater, and an RPE rating of 18 or greater (ACSM, 2000). 
 
Exercise-control trials  
 Subjects reported to the laboratory on a separate day, at least 72 hours but no more 
than 7 days following their initial visit.  They reported to the laboratory for these tests at the 
same time of day (±30 minutes) for each trial. During these testing trials, the subjects had 
three blood draws performed and concurrently three saliva samples collected.  
 First, the subjects filled out the REST-Q questionnaire and if normal scores were 
demonstrated, they began their supine resting period.  After 30 minutes, pre-exercise blood 
and saliva samples were taken. Next, the subject began a 5-minute warm up on the cycle 
ergometer at very low intensity (approximately 15-20 % of VO2 max). Subjects were then 
instructed to stretch for 5 minutes after which they mounted the cycle and began the exercise 
trial.  The predetermined workload was to elicit 40%, 60%, or 80% of subjects‘ VO2 max, 
calculated using from the initial visit using a regression analysis predicting oxygen utilization 
responses based on workload.  The 20% differences in the intensities of each of the exercise 
trials were chosen to prevent any potential overlap in workloads within each subjects‘ 
exercise trials. The workload was set beforehand, but was occasionally adjusted after the 
protocol was initiated based on the subjects‘ metabolic responses.  The reported workloads 
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were mean values calculated over the duration of the 30 minutes of exercise.  The 20% 
differences in the intensities of each of the exercise trials were chosen to prevent any 
potential overlap in workloads within each subjects‘ exercise trials. 
 Heart rate was monitored every five minutes, and metabolic data was collected for 
three minutes at three points (minutes 7-10, 17-20, and 27-30) during the test to verify the 
workload met the prescribed intensity.  After the 30 minutes of exercise at the prescribed 
workload was completed, the immediate post-exercise blood and saliva samples were 
collected (See Figure 4).  After the blood sample was taken, subjects were allowed to 
actively cool down on the cycle ergometer, followed by a resting period.  After 30 minutes 
recovery post-exercise, the last blood and saliva samples were collected.  The subject was 
allowed to leave the laboratory after their heart rate reached approximately 100 bpm. This 
process was replicated for each of the exercise trials. For the resting control trial, the above 
procedures were repeated, but a 30-minute rest period was substituted for the exercise. These 
four trials were randomized and separated by a minimum of 72 hours.  
 
 
Subject           Blood Sample    Blood Sample               Blood Sample 
Arrived           Saliva Sample    Saliva Sample               Saliva Sample 
    
      30 min. rest      30 min. exercise  30 min. rest 
        (supine)           5 min            or rest         (supine) 
 
 
     
           Warm-up                Subject Left 
 
Figure 4. Overview of typical experimental trial. 
 
 
24 
 
Instrumentation 
  
 The height (cm) and body mass (kg) of each of the subjects were determined using a 
stadiometer (Perspectives Enterprises, Portage, MI) and a mechanical scale (Detecto, Webb 
City, MO). Body fat percentage was measured in triplicate at select sites (abdomen, chest, 
and thigh) using Cambridge Lange skinfold calipers (Cambridge Scientific, Cambridge, MA) 
and calculated using Jackson-Pollock method (Jackson et al., 1978). Respiratory gases were 
measured using a Parvo Medics TrueMax 2400 Metabolic System (Parvo Medics, Salt Lake 
City, UT, USA) and all exercise (maximal and submaximal) was completed on a Lode 
electronically braked ergometer (Lode, Groningen, The Netherlands).  Heart rate was 
monitored during the exercise using a Polar HR monitor (Polar Model F1, Finland).  Ratings 
of perceived exertion (RPE) were determined using Borg‘s 6-20 scale rate of perceived 
exercise scale (Borg, 1970).   
 
Specimen procedures 
 Collection and storage 
 After placement of a catheter, blood samples (3 ml) were collected using a 3-cc 
syringe (Vanishpoint) and a 25 gauge needle (Retractable Technologies, Inc., TX, USA).  All 
samples were immediately transferred into a sterile K
2 
EDTA (purple top) tube (Vaccutainer) 
and were kept cool by being put on ice. For each exercise intensity, pre-trial, post-trial, and 
post-recovery hematocrit (Hct) were assessed in triplicate, using 75 mm microcapillary tubes 
(Fisher Scientific, PA, USA) sealed with Critoseal (Krakeler Scientific, Inc., Albany, NY).  
Samples were spun using the Adams MHCT II  microhematocrit centrifuge (Becton 
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Dickinson, Franklin Lakes, NJ) for three minutes and subsequently read with a micro-
hemoatocrit reader (International Equipment Company, Needham Heights, MA).  
 Resting (pre-trial), post-trial, and post-recovery hemoglobin (Hb) levels were also 
assessed in triplicate fashion from whole blood using the Stat-Site, WT-9‖ Hemoglobin 
Meter (Stanbio Laboratory, Boerne, TX). Using the mean Hct and Hb values, the changes in 
plasma volume were calculated for each trial using the Dill and Costill method (Dill & 
Costill, 1974).  These changes indicated the effect of exercise induced fluid shifts on cortisol 
concentrations.  Ultimately, the data analysis assessing serum cortisol concentrations were 
uncorrected for fluid shifts were used when comparing salivary and serum collection 
methods.  After the initial whole blood analysis, the blood samples were spun at 3000 rpm 
and 4 degrees Celsius using a refrigerated centrifuge (IEC Cenra-8R, International 
Equipment Company, Needham Heights, MA) to separate plasma from erythrocytes.  The 
plasma was pipetted into cryo-freeze tubes and stored at -80 degrees Celsius in an ultra-
freezer (Revco Scientific, Inc., NC, USA).   
 Prior to collection of saliva samples, subjects were asked to rinse their mouths with 
water, spit, and then allow saliva to accumulate in the pool of their mouth.   If saliva 
secretion needed to be stimulated, subjects were asked to chew on paraffin film.  
Accumulated saliva samples (minimum of 0.5 ml necessary) were collected from the 
subjects‘ mouths directly into a polypropylene cup.  No more than 5 minutes past the desired 
time point was allowed to pass before saliva was collected.   Collected samples were stored 
at -80 degrees Celsius.   
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Biochemical analysis 
 The stored serum and saliva samples were removed from storage allowed to warm to 
room temperature and then assessed for cortisol concentrations.  Total serum cortisol 
concentrations were measured using a single-antibody, solid-phase radioimmunoassay (RIA) 
technique (Siemens Health Care, USA).  Stored saliva samples were thawed and spun at 
3000 rpm and 4 degrees Celsius. The saliva cortisol levels were measured using an expanded 
range high sensitivity enzyme immunoassay (EIA) kit (Salimetrics, State College, PA, USA). 
 It is important to note that free cortisol represents approximately 10% or less of the 
total cortisol amount found in the serum.  This free portion of this hormone is what 
influences concentrations in the saliva and why absolute salivary concentrations are typically 
substantially lower than the total serum cortisol concentrations (Hellhammer et al., 2009). 
 
Data analysis 
 Data analysis was performed using a computer based statistical software program 
(SPSS version 17.0, LEAD Technologies, Inc., Chicago, IL, USA). Mean and standard 
deviations for values for height, mass, age, body fat %, and VO2 max were computed.  
 Separate, 4 x 3 (trial x sampling time), repeated measures analysis of variance 
(ANOVA) tests were used to determine if significant changes occurred in serum and saliva 
cortisol levels within each of the experimental trials (40%, 60%, 80% exercise intensity, 
control-rest). If the omnibus ANOVA analysis revealed significant findings, Tukey post-hoc 
tests were used to determine which means were significantly different. The significance level 
was set a priori at α ≤ 0.05. 
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 Pearson product-moment correlations were used to assess the relationships between 
serum and salivary cortisol concentrations. The ―r‖ values of the correlational analyses were 
used to compare pre-trial, post-trial, and post-recovery levels at each exercise intensity (40%, 
60%, and 80%) and the control trial to determine how well the two methodologies compared 
at each respective time interval within subjects. 
  
 
 
 
 
CHAPTER IV 
RESULTS 
Subject characteristics 
 Twelve moderate to high endurance-trained athletes participated in this investigation.  
Eleven of the twelve subjects completed all aspects of the study and one subject resigned 
from participation after completing two of the trials. The physical characteristics of the 
subjects (n = 12), expressed as mean ± standard deviation (SD) were as follows: age (years) 
= 22.0 ± 4.6; height (cm) = 174.9 ± 7.1; mass (kg) = 66.5 ± 9.5; BMI (kg/m
2
) = 21.6 ± 1.9; 
and body fat (%) = 8.4 ± 2.1.  All subjects were training for a minimum of three days per 
week for 60 minutes or more in the previous six months before they began the protocol. The 
subjects in the study had various backgrounds of training and sport participation, but 
primarily were experienced in endurance events, including cycling and running. To be 
included in the study, each of the subjects had to have a daily dietary intake consisting of at 
least 50% of calories (kcal) from carbohydrates (CHO).  The subjects‘ mean CHO intake was 
57.9% ± 3.7%.  All of the subjects reported they had adhered to the experimental guidelines 
(see Methods) before the VO2max session and experimental exercise and control trials (Trials 
I-IV).  
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VO2maxtesting 
  
Each of the subjects completed the VO2max testing at least 7 days prior to the initiation 
of the experimental trials.  All of the twelve subjects met the criteria for a valid test. The 
results of the VO2max tests are displayed below in Table 1. 
 
Measure Value 
Absolute VO2 max (L/min) 3.84 ± 0.43 
Relative VO2 max (ml/kg/min) 58.2 ± 6.4 
Peak Heart Rate (bpm) 194 ± 6 
Peak RER 1.09 ± 0.04 
Peak RPE 19 ± 1 
Length of Test (min) 15.6 ± 2.0 
Table 1.  Mean values of the VO2 max test for the subjects (n = 12). Values are expressed as 
mean ± standard deviation (SD). 
 
 
Experimental testing trials 
 
The results of the exercise trials indicate that the prescribed intensities were slightly 
higher than desired but did not overlap; therefore, the desired approximate 20% difference in 
intensities was achieved. Subjects also completed a trial during which no exercise was 
performed and served as a control trial for which to compare to the exercise trials.  The 
results of the experimental testing trials are displayed below in Table 2. 
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Measure 40% VO2 max 60% VO2 max 80% VO2 max 
Workload (W) 95.0 ± 17.0 145.4 ± 18.8 181.9 ± 26.1 
Heart Rate (bpm) 127 ± 14 156 ± 14 180 ± 8 
VO2 (ml/kg/min) 26.3 ± 3.3 37.8 ± 4.3 49.4 ± 4.6 
% VO2 max 45.3 ± 5.0 65.2 ± 7.7 85.0 ± 5.8 
RPE 10 ± 2 13 ± 2 16 ± 1 
Table 2.  Results (average over 30 min. of exercise) of select variables measured during each 
respective exercise trial (n = 12). Values are expressed as mean ± standard deviation (SD). 
 
 
Plasma volume changes 
  
 Plasma volume (PV) changes as a result of the experimental trials were calculated 
from mean Hb and Hct values collected pre-trial, post-trial, and post-recovery.  The greatest 
mean PV shifts from pre-trial to post-trial as well as from pre-trial to post-recovery occurred 
during the 80% experimental trial.  Table 3 displays these changes. 
Table 3. Mean Hct, Hb values for pre-trial, post-trial and post-recovery with corresponding 
plasma volume changes (% changes) from pre-trial to post-trial and from pre-trial to post-
recovery (n = 12). All values are expressed as mean ± standard deviation (SD). 
 
 
 
 
Trial 
Hct (%) Hb (g/dL) Δ Pre-
Trial to 
Post-Trial 
Δ Pre-
Trial to 
Post-
Recovery Pre Post Rec Pre Post Rec 
Control  38.9 ± 0.6 39.8 ± 0.4 39.3 ± 0.4 14.1 ± 1.2 14.8 ± 1.0 14.6 ± 1.0 -6.1 ± 3.3 -4.2 ± 2.0 
40%  37.7 ± 0.3 40.4 ± 0.4 39.3 ± 0.4 14.2 ± 0.9 15.3 ± 0.9 14.5 ± 0.9 -11.1 ± 4.2 -5.1 ± 4.4 
60%  38.2 ± 0.3 41.0 ± 0.3 39.8 ± 0.4 14.0 ± 1.0 14.8 ± 0.7 14.5 ± 0.8 -10.4 ± 4.4 -6.1 ± 5.0 
80% 38.1 ± 0.4 41.2 ± 0.4 39.9 ± 0.4 14.1 ± 0.9 15.5 ± 1.5 14.8 ± 0.9 -14.2 ± 5.6 -8.0 ± 4.0 
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Cortisol analysis 
  
 The mean (± SD) serum and salivary cortisol responses to the different experimental 
trials analyzed at the three respective sampling time points are highlighted in Tables 4 and 5. 
These hormonal values were not corrected for PV changes. 
Serum cortisol 
Table 4. Mean serum cortisol concentrations for each respective experimental trial (n=12).  
Values are expressed as mean ± standard deviation (SD). 
*Significant difference from respective pre-trial (p < 0.05). 
**Significant difference from respective post-trial (p < 0.05). 
 
 Control/resting trial: For the control/resting trial, serum cortisol concentrations 
decreased slightly during the first 30 minutes of rest and then increased slightly during the 
last 30 minutes of rest.  However, these changes were not significant. 
 40% VO2 max exercise trial: The cortisol concentrations decreased from pre-trial to 
post-trial and also decreased from post-trial to post-recovery. However, these changes were 
not significant. 
 60% VO2 max exercise trial: Cortisol concentrations increased slightly from pre-trial to 
post-trial, but these changes were not significant.  However, from post-trial to post-recovery, 
Trial 
Serum Cortisol Concentrations (µg/dL) 
Pre-Trial Post-Trial Post-Recovery 
Control  12.2 ± 5.4 9.8 ± 4.3 10.5 ± 4.9 
40% VO2 max 14.3 ± 7.0 13.8 ± 6.0 10.9 ± 4.3 
60% VO2 max 14.0 ± 4.5 16.2 ± 5.1 11.1 ± 5.1** 
80% VO2 max 12.2 ± 4.4 20.5 ± 6.7* 20.5 ± 7.8* 
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cortisol responses decreased by 31.2% (p = 0.006). The peak cortisol response in this trial 
occurred at the post-trial sampling time. 
 80% VO2 max exercise trial: Cortisol responses increased significantly from pre-trial to 
post-trial (p ≤ 0.001) as well from pre-trial to post-recovery (p ≤ 0.001).  These significant 
increases represented identical 40.4% elevations from pre-trial concentrations at each of the 
respective time intervals (post-trial and post-recovery).  The peak cortisol response in this 
trial was at the post-trial sampling time (i.e. when concentrations were expressed to the 
second decimal place); although there was no difference between mean values at post-trial 
and post-recovery sampling times.   
 
Salivary cortisol 
 
Table 5. Mean (± SD) cortisol concentrations for each respective experimental trial. Values 
are expressed as mean ± standard deviation (SD). 
*Significant difference from respective pre-trial (p < 0.05). 
 
 Control/resting trial: For the control/resting trial, salivary cortisol concentrations 
decreased slightly during the first 30 minutes of rest and again from minute 60 to minute 90 
of rest.  However, none of these changes were significant.  
Trial 
Salivary Cortisol Concentrations (µg/dL) 
Pre-Trial Post-Trial Post-Recovery 
Control  0.256 ± 0.168 0.251 ± 0.148 0.224 ± 0.200 
40% VO2 max 0.268 ± 0.204  0.213 ± 0.157  0.190 ± 0.138  
60% VO2 max 0.189 ± 0.114  0.293 ± 0.133  0.259 ± 0.165 
80% VO2 max 0.170 ± 0.073  0.349 ± 0.216*  0.460 ± 0.251* 
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 40% VO2 max exercise trial: The cortisol concentrations in the saliva in this trial were 
very similar to the responses during the control trial.  Levels decreased slightly immediately 
post-trial and again dropped slightly from post-trial to post-recovery. Once again, none of 
these changes in salivary cortisol levels were significant. 
 60% VO2 max exercise trial: Cortisol concentrations in the saliva in this trial mirrored 
the responses of those in the serum during the same experimental trial, but were not as 
robust. Responses increased slightly from pre-trial to post-trial and again from post-trial to 
post-recovery.  However, none of these salivary changes were significant. The peak cortisol 
response in this trial occurred at the post-trial sampling time. 
 80% VO2 max exercise trial: During the 80% trial, salivary cortisol responses increased 
significantly from pre-trial to post-trial (p = 0.01) and also from pre-trial to post-recovery (p 
≤ 0.001).  No other significant changes were noted. The peak cortisol response in this trial 
occurred at the post-recovery sampling time. 
 
Cumulative serum versus salivary cortisol responses 
 
To determine how well serum-saliva concentrations tracked, a composite correlation 
analysis (Pearson Product Moment) was used to assess the aggregate relationship between 
the two sampling methodologies.  Figure 5 displays this relationship, where the correlation 
coefficient for the two methods was r = 0.548, which was significant (p < 0.005). 
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Figure 5. The relationship between matched serum and salivary cortisol responses across all 
experimental conditions and time intervals.  
 
 
Serum versus salivary cortisol responses within sessions 
 
 Pearson Product Moment correlations were used to compare sampling methods within 
each experimental trial (40%, 60%, 80% VO2 max and control) at each specific time point 
during a trial. These correlations measured the associations between the matched pairs for 
serum and saliva within the respective trial and sampling time point. These results are 
highlighted in Table 6.  The highest correlations between the methods were in the control and 
40% VO2max trials when comparing across experimental trials.  When evaluating the two 
methods across the sampling times, the highest correlations tended to be during the post-
recovery time point.   
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Table 6.  Pearson Product Moment correlation coefficients for serum vs. salivary cortisol 
concentrations for each respective experimental trial. 
*Indicates significant correlations (p < 0.05) 
 
 
 
 
Trial 
Pearson Product Moment Correlation Coefficients 
Pre-Trial Post-Trial Post-Recovery 
Control  r = 0.627* r = 0.797* r = 0.476 
40% VO2 max r = 0.826* r = 0.591* r = 0.706* 
60% VO2 max r = 0.103 r = 0.351 r = 0.644* 
80% VO2 max r = 0.047 r = 0.053 r = 0.426 
                                                                                
 
 
 
 
CHAPTER V 
 
DISCUSSION 
 
Introduction 
  
 The primary purpose of this study was to investigate the associations between serum 
and salivary cortisol responses at three different exercise intensities (40%, 60%, and 80% of 
VO2 max), to determine if salivary concentrations could be an accurate method to assess the 
body‘s response to exercise. The hypothesized outcome was that there would be significant 
correlations between the serum and salivary cortisol levels at all sampling times. It was also 
expected that the peak salivary cortisol response when compared to the peak serum response 
within the 60% and 80% exercise trials would occur at a later sampling time.  This was 
predicted since the movement of free cortisol from the capillaries into the saliva is passive; 
thus, the peak response of the hormone due to the exercise was expected to be delayed 
compared to the peak responses in serum concentrations.  
 The discussion in this chapter is organized into several sections.  First, there is a 
discussion about the subjects‘ physiological responses to the exercise trials, focusing on the 
how close the subjects were to the desired exercise intensities. Second, both the subjects‘ 
serum and salivary cortisol responses are discussed, analyzing how they compared to other 
related exercise studies. Third, there is a discussion of how the associations between the 
methods compared to previous studies which evaluated the relationship between these 
methods. Fourth, the peak responses of cortisol in the moderate and high intensity trials are 
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compared and addressed.  Finally, limitations and conclusions of the present study are 
discussed. 
 
Exercise responses 
 As highlighted in Table 2, the exercise trials produced the desired physiological 
responses from the subjects.  A regression equation was used to predict the workload that 
would bring about the prescribed intensities and the workload was adjusted at 10 minutes 
and/or 20 minutes into the trial if the VO2 responses were higher or lower than what was 
stipulated. Ultimately, the average intensities over the 30 minutes of exercise were slightly 
higher than what was predicted, 45.3 ± 5.0%, 65.2 ± 7.7%, and 85.0 ± 5.8%, respectively. 
However, none of the responses overlapped.  This was also apparent when looking at the 
heart rates (95 ± 17 bpm, 145 ± 19 bpm, and 182 ± 26 bpm, respectively), and RPE values 
reported by the subjects during the trials (10 ± 2, 13 ± 2, and 16 ± 1, respectively).  These 
findings suggest the desired effect for the experimental exercise protocol was achieved.  
Hematocrit and hemoglobin values were measured within each blood sample in order to 
calculate plasma volume shifts (Dill & Costill, 1974).  These hematological measures were 
assessed to determine if the subjects were well hydrated at the start of each trial for each of 
the experimental trials and normal hemodynamic responses to exercise occurred. Results 
support that all subjects were adequately hydrated and their fluid responses to exercise were 
normal and in agreement with the literature (Hagen et al. 1980).  
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Cortisol responses 
Serum 
All serum values were within the normal expected range of values for the all the 
respective measurement times and experimental trials (Siemens Health Care, USA).  During 
the control and the 40% exercise trials, serum cortisol responses decreased from pre-trial 
levels both immediately after rest or exercise as well as at the post-recovery from rest or 
exercise.  The decrease in cortisol during the rest of the control trial is reflective of the 
normal circadian pattern for cortisol (Kerrigan et al., 1993).  The 40% exercise trial results 
are consistent with previous studies analyzing the threshold-intensity effect.  That is, while 
there are some divergent findings, most literature has supports a ~60% exercise intensity 
threshold is necessary to elicit a significant increase in blood cortisol (Davies & Few, 1973; 
Hill et al., 2008).   
 During the 60% exercise trial, cortisol responses did not significantly increase as was 
expected (Davies & Few, 1973).  While levels were elevated by 16% compared to pre-trial 
levels, the increase was not significant at this intensity. This may be explained by the high 
aerobic fitness level (>50 ml/kg/min) of the subjects.  Persons who are highly trained tend to 
have a higher intensity threshold to provoke an increase in cortisol (Bloom et al., 1973; Viru 
& Viru, 2004).   
 Another unexpected finding during the 60% trial was that the cortisol responses 
significantly decreased from post-trial to post-recovery.  Levels were expected to decrease in 
the serum during recovery, but it was projected that the levels would not significantly drop to 
below those measured before the exercise.  Why this change occurred is unclear, but it could 
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reflect the circadian pattern of cortisol secretion and/or a natural decline in the hormonal 
levels as a function of feedback regulation (Few et al., 1970; Kerrigan et al., 1993). 
During the 80% trial, cortisol responses significantly increased from rest (pre-trial) 
and remained elevated during the 30 minute recovery from the exercise trial.  This finding 
concurs with several studies which used similar designs to the present study (Bloom et al., 
1973; Davies & Few, 1973; Hill et al., 2008).  This prolonged elevation in cortisol during the 
recovery period has been previously found following intensive, stressful exercise and 
demonstrates hormonal changes can last well past the cessation of exercise (Daly et al., 
2004). 
 
Saliva 
 
All saliva values were within the normal expected range of values for the all the 
respective measurement times and experimental trials (Salimetrics, USA).  For the control 
session and the 40% exercise trial, salivary cortisol responses followed the same trend as 
serum cortisol; that is, levels decreased from pre-trial to post-trial and remained depressed 
after the 30 minute recovery trial.   However, these changes were not significant.  For the 
60% trial, levels did not significantly increase from that of the pre-trial measurement.  
Despite an average increase of 35% in the 60% trial, the increase was not significant due to 
the high variability of responses within the subjects.  Levels still remained elevated (23%) at 
post-recovery compared to pre-trial unlike the significant decrease evident in the serum 
concentrations within this trial.  
The intensity-threshold effect was clear in the 80% exercise trial as levels 
significantly increased from pre-trial to post-trial.  This is in agreement with previous studies 
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using saliva sampling assessing cortisol responses to varying exercise intensities.  For 
example, Jacks and colleagues demonstrated the threshold-intensity effect in salivary cortisol 
utilizing 3 different exercise intensities (mean intensities of 44.5 %, 62.3, and 76.0 %). 
During the highest-intensity exercise session, cortisol was significantly higher after the 
exercise session (p = 0.004) compared to baseline (Jacks et al., 2002).  Kivlighan and 
colleagues also used saliva as the sampling specimen for obtaining cortisol responses to the 
anticipation of a competitive (high intensity) exercise session as well as during the recovery 
period after the exercise. Levels significantly increased from baseline in all groups 
(competitive and non-competitive males and females) after the exercise session (Kivlighan et 
al., 2005).  
 Some studies employing resistance exercise have also demonstrated significant 
increases in cortisol responses measured in the saliva. For example, McGuigan and 
colleagues found that high intensity (75%) resistance exercise resulted in significant (p < 
0.05) increases in salivary cortisol compared to resting levels.   Low intensity resistance 
exercise (30%) did not result in any significant increases (McGuigan et al., 2003).  Also, 
Paccotti and colleagues found that there was a significant increase (p < 0.05) in salivary 
cortisol levels in competitive athletes immediately after an acute bout of high intensity 
resistance training.  Cortisol levels also remained significantly elevated at 90 and 120 
minutes after termination of the exercise (Paccotti et al., 2005). 
 The unique response in the present study was salivary concentrations were highest 
(and possibility still increasing) after 30 minutes of recovery from the 80% trial.  This was 
evidenced by 31% higher average concentrations comparing post-trial to post-recovery. This 
finding is divergent from that of Jacks et al. who also used recovery sampling as part of their 
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experimental design in measuring cortisol in saliva and found cortisol levels remained 
elevated from rest after 20 minutes of recovery from a 60 minute exercise bout on a cycle 
ergometer, but were still slightly lower than levels measured immediately post-exercise 
(Jacks et al., 2002).  The relatively long exercise duration of 60 minutes of this latter study 
may have allowed sufficient time for the diffusion of the free cortisol levels into the saliva 
during the recovery.  Thus, there was not as great a potential for a temporal lag between 
responses.  The present study utilized a shorter exercise duration which may have been an 
inadequate amount of time for saliva levels to completely reflect the blood levels (Ben-Aryeh 
et al., 1989). 
 
Comparison of serum to salivary cortisol 
The composite correlation coefficient between serum and saliva cortisol was 0.548, 
which was significant (p < 0.005).  This relationship is displayed in Figure 7. The high level 
of significance can be partially attributed to the large sample size (n = 135).  While this is a 
moderate correlation and it appears the two methods track well, this correlation coefficient 
was lower than what was expected based on previous literature.  Kirschbaum and colleagues‘ 
reported correlation coefficients between cortisol in saliva and cortisol in serum ranging from 
r = 0.71 to r = 0.96 (Kirschbaum et al., 1994).  Umeda and Iwaoka‘s investigation also 
reported a strong correlation coefficient of r = 0.893 (n = 10; p < 0.001) between serum and 
saliva, which was significant considering the small sample size Umeda & Iwaoka, 1981).  
Goodyer and colleagues also found correlations that were significant (r = 0.81; p < 0.005) but 
had a large sample size (n =284) which may have contributed to the relationship (Goodyer et 
al., 2001). However, Gonzansky and colleagues yielded results with less robust correlations, 
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with a coefficient between serum and saliva cortisol of r = 0.60, which was significant 
(Gonzansky et al., 2005).  
The primary difference between the present study and these previous studies are the 
means of stimulation of the HPA axis. Many of the above studies measured cortisol levels in 
a resting state and not using exercise as a stressor. For example, in Umeda and Iwaoka‘s 
(1981) investigation, instead of using exercise as a stimulus to the HPA axis, they used 
ACTH stimulation to elevate levels of cortisol (Umeda & Iwaoka, 1981). Since there is more 
variance using exercise as a stressor to the HPA axis compared to synthetic augmentation 
(Paccotti et al., 2007), this may partially explain the difference in the strength of the 
associations between this study and the present study.  
 
Comparison of serum and salivary cortisol during exercise 
 A major aim of this study was to evaluate the relationship between serum and salivary 
cortisol responses to 30 minutes of exercise of different intensities at different sampling 
times.  To assess this outcome, correlations for each of the respective trials (control, 40%, 
60%, 80%) and sampling times (pre-trial, post-trial, and post-recovery) were used to gauge 
how well the methods were associated with one another.  Table 6 lists each of the 
correlations and indicates which correlations are significant within a particular experimental 
trial.  
  Pre-trial concentrations were highly correlated before the control trial as well as the 
40% trial.  However, correlations were very weak at the same time point for the 60% and 
80% trial, which was unexpected.  All pre-trial resting cortisol levels were expected to be 
correlated based upon the studies discussed in the section above.  This finding of low 
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correlations for the 60% and 80% trials at rest is difficult to explain.  Methodological flaws 
in the assay procedures are not a likely factor. All assay coefficients of variation (CV) were 
at less than 10% for serum and saliva determinations.  Also, all assay quality control 
standards were within acceptable ranges of variance (5-10%).  At this time, no explanation 
for the lack of significant correlations at rest in the 60% and 80% trial can be given. 
 Post-trial hormone levels were significantly correlated within the control, 40% and 
60% trials but not in the 80% trial.  The lack of association between the serum-saliva 
specimens after highest intensity exercise trial was anticipated, and may be due to the 
proposed diffusion rate differences between the blood-saliva at higher hormonal 
concentrations (Ben-Aryeh et al., 1989; Vining et al., 1983).  The significant correlations 
immediately after exercise agree with some previous studies.  For example, Thomasson and 
colleagues compared plasma and saliva hormones in response to exercise, but only measured 
cortisol response to an exercise intensity of 50-55% VO2 max.  There were significant 
correlations (p < 0.05) at rest; but the correlations measured throughout the steady-state 
exercise bout were low to moderate (r = 0.35), although still significant (p < 0.02) 
(Thomasson et al., 2009).  Also, Cadore and colleagues found that correlation between serum 
and salivary cortisol responses after resistance exercise were somewhat stronger (r = 0.62, p 
= 0.001) than reported here.  However, this resistance exercise was of an undefined intensity; 
therefore, it is difficult to make valid comparisons to the present study (Cadore et al., 2008). 
 In the present study, the post-recovery levels tended to have higher correlations 
across all of the experimental trials when compared to the other sampling time points. 
However, only the 40% (r = 0.706) and 60% (r = 0.644) trials were at a significant level, 
whereas after the 30 minute recovery, the control and 80% correlations only approached 
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significance (p = 0.10-0.15).  Few studies have examined the relationship between serum-
saliva cortisol concentrations during the recovery from exercise.  Neary and colleagues 
compared serum and saliva concentrations one day into the recovery from an exercise 
training session and found that serum and saliva concentrations were highly associated, r = 
0.99 (Neary et al., 2002).   However, the long recovery period (1 day) was significantly more 
time than the present study (30 minutes), which make comparisons between the two studies 
somewhat problematic. The lack of significance between the serum-saliva measurements 
after the 30 minute recovery from the 80% trial is likely due to the fact that salivary 
concentrations were still increasing compared to the leveling off seen in the serum.  The lack 
of a significant correlation in the recovery from the 80% trial may be evidence for the 
hypothesized diffusion rate differences between salivary cortisol responses compared to 
serum responses.   
 Peak responses 
 When comparing peak responses in serum and saliva in the 60% trial, both occurred 
immediately after the exercise, meaning that the mean responses mirrored each other even 
though the concentrations were not significantly correlated at this sampling time.  This was 
different than what was hypothesized because it was predicted that concentrations in the 
saliva would peak at a later time point (post-recovery) in this trial compared to serum.  This 
may be explained by the fact that since cortisol responses were not significantly augmented 
with either sampling technique during the 60% trial, the magnitude of increase was not large 
enough to elicit a delay in the response of the saliva compared to serum. 
 In the 80% trial, the peak response occurred at a later time point (post-recovery) when 
saliva was compared to serum (post-trial).  This is in agreement with the second research 
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hypothesis and supports that salivary cortisol responses may be delayed due to the passive 
movement of the hormone from the blood into the saliva (Ben-Aryeh et al., 1989).  This 
delayed response may be due to the lack of blood flow during exercise to the mouth area (i.e. 
salivary glands) where saliva is produced.  Blood is shunted to the working skeletal muscle 
during exercise.  The reduced blood flow at the mouth could decrease the cortisol available to 
cross from the capillaries to the saliva through the passive diffusion process. However, once 
the exercise is complete, the blood is steadily redistributed from the muscle to the rest of the 
body (Brooks et al., 2000). During recovery from exercise the amount of blood flow to the 
mouth would slowly return to normal, thereby increasing the amount of free cortisol 
available to diffuse from the blood into the saliva. This delayed response accentuates the 
need to include sampling during the recovery from intense exercise when assessing salivary 
cortisol responses since peak salivary levels occur at a later time point than in serum for the 
80% high intensity exercise. 
 
Limitations of study 
 There are potential limitations and confounding factors in this investigation which 
may have impacted the results and potentially limit the reliability and validity of the findings.  
First, both small sample size (n = 12) and the demographics of the subjects (trained male 
athletes 18-30 years of age) make it difficult to generalize the findings to other populations.  
Second, some subjects completed their trials in the morning while others completed their 
trials in the afternoon, potentially causing differing responses between subjects; although, 
each respective subject did consistently replicate the time of day for each of their trials. 
Third, the researchers relied on the truthfulness of the subjects in providing background 
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information and adhering to experimental compliance procedures, including: medical 
information, training history, dietary records, acute training (no strenuous exercise in the 24 
hours prior to the trials), diet (4 hours post prandial, and no alcohol, NSAIDs, or caffeine in 
the previous 8 hours) and stress states (forthright answers in the REST-Q questionnaire). 
Inaccuracies in the information and/or procedures may have introduced systematic error into 
the study and confounded outcomes. 
 The collection of samples of serum and saliva may have also introduced error into 
study.  The drawback of blood sampling is that venipuncture can elicit stressful responses 
that could lead to rapidly elevated blood cortisol levels.  This ‗white-coat‘ effect cannot be 
disregarded if testing is carried out where both the testing situation and personnel are 
unfamiliar and in situations where subjects remain in anticipation of the venipuncture 
(Levine et al. 2007). Although in the present study, subjects rested for 30 minutes before the 
first blood sample was taken as well as experienced the procedure on four separate occasions, 
which might have mitigated some of this effect. Finally, the sampling procedure for saliva 
can be problematic.  Saliva which is provided after eating or drinking substances with low 
pH interferes with assay results; although, the current subjects were supposed to have been 4 
hours post-prandial as noted above. Also, the presence of blood in saliva due to oral lesions 
can affect salivary assay results (Schwartz & Granger, 2004).  The current subjects did not 
have their mouths inspected prior to saliva collections to determine if this could have been a 
problem. The researcher tried to control all of these factors through sufficient planning, 
dialogue with the subjects, and collection in controlled environment; nonetheless, errors and 
oversights may still have occurred. 
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Summary  
The present study is one of the only studies comparing serum and saliva cortisol 
levels at varying exercise intensities and recovery from exercise. Collectively, the results 
suggest salivary measurements of cortisol can, in some circumstances mirror those in serum 
in response to exercise. However, the present data do not support that salivary cortisol and 
serum cortisol perfectly track one another at different intensities of exercise. 
As the saliva cortisol measurement method becomes more established, it may prove 
to be very beneficial to the field of sports physiology.  Assessing cortisol allows for the 
opportunity to collect the samples without medical personnel, it minimizes stress in the 
collection process, permits frequent and rapid sampling, and facilitates sampling in a variety 
of environments.  These advantages are specifically relevant for athletes, since practice and 
competitions take place outside of the laboratory environment. 
  
 
 
 
CHAPTER VI 
 
SUMMARY, CONCLUSIONS AND RECOMMENDATIONS 
 
Despite the limitations of this study, there are many insights that can be gained from 
the findings. When analyzing specific intensities and time points, correlations between the 
serum-saliva sampling techniques were significant after recovery from exercise at 40% and 
60% of VO2 max.  The intensity threshold effect was evident in both sampling methods during 
the 80% intensity, suggesting that salivary concentrations are similar to serum comparing 
across subjects.  Finally, there was evidence for a hypothesized delay in the peak levels 
measured in the saliva after recovery from the high intensity (80%) trial.  However, there 
needs to be more research completed on this topic, utilizing more subjects and perhaps 
introducing a longer period of recovery into the experimental protocol, especially during high 
intensity exercise.  Nonetheless, the findings of this study suggest that salivary measurement 
of cortisol may be a viable option for assessing this hormone as long as research personnel 
are aware of sources of variance and differences from serum sampling. 
Salivary cortisol sampling may be preferable to serum. Since cortisol is a stress 
hormone, measuring this hormone from blood sampling introduces stress in the sampling 
process itself, which is potentially a major confounding factor (Levine et al., 2007). 
Collection of saliva, on the other hand, is less invasive, is much easier than setting up the 
blood draws and requiring a phlebotomist to be present.   However, particularly when using 
this sampling technique in exercise studies, being aware of confounding factors and sources
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of variance is crucial when drawing conclusions. Monitoring levels of this hormone 
throughout and between training cycles may lend insight into the stress that an exercise 
program provides and may enlighten coaches, athletes, and research personnel to the optimal 
stimuli to promote adaptation to training. 
 
Conclusions 
Research hypothesis #1: There will be significant correlations between serum and 
salivary cortisol concentrations at the pre-trial, post-trial, and post-recovery sampling time 
within each of the experimental trials (control, 40%, 60% and 80% VO2 max exercise).  This 
hypothesis was rejected since only 6 of the 12 correlations were significant. 
Research hypothesis #2:   The peak saliva cortisol response when compared to the 
peak serum response within the 60% and 80% exercise trials will occur at a later sampling 
time.  This hypothesis was rejected for the 60% exercise, but accepted for the 80% exercise.  
Both the serum and saliva peak responses occurred immediately post-trial in the 60% 
exercise trial, which did not support the research hypothesis.  However, in the 80% exercise, 
trial, the peak response for salivary cortisol occurred during a later sampling time (30 
minutes; post-recovery) than with serum (post-trial), which agreed with the research 
hypothesis. 
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The forms and information in Appendix A and Appendix B are a copyright of the University 
of North Carolina-Chapel Hill Department of Exercise and Sport Science (EXSS).
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APPENDIX A 
 
MEDICAL HISTORY 
Department of Exercise and Sport Science 
Medical History 
 
Subject: __________________________ ID: ___________  Telephone:______________ 
 
Address:________________________________________________________________ 
 
Occupation:___________________________________  Age:______________________ 
 
          YES NO 
Patient History 
1. How would you describe your general health at present? 
Excellent______ Good_______ Fair______ Poor______ 
2.   Do you have any health problems at the present time?   _____ _____ 
3.  If yes, please describe:         
             
4.  Have you ever been told you have heart trouble?    _____ _____ 
5.  If yes, please describe:         
             
6.  Do you ever get pain in your chest?     _____ _____ 
7.  Do you ever feel light-headed or have you ever fainted?   _____ _____ 
8.  If yes, please describe:         
             
9.  Have you ever been told that your blood pressure has been elevated? _____ _____ 
10.  If yes, please describe:         
             
11.  Have you ever had difficulty breathing either at rest or with exertion? _____ _____ 
12.  If yes, please describe:         
             
13.  Are you now, or have you been in the past 5 years, under a doctor‘s care for any reason?
         _____ _____ 
14.  If yes for what reason?         
             
15.  Have you been in the hospital in the past 5 years?   _____ _____ 
16.  If yes, for what reason?         
             
17.  Have you ever experienced an epileptic seizure or been informed that you have epilepsy?
         _____ _____ 
18.  Have you ever been treated for infectious mononucleosis, hepatitis, pneumonia, or 
another infectious disease during the past year?    _____ _____ 
19.  If yes, name the disease:          
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20.  Have you ever been treated for or told you might have diabetes? _____ _____  
21.  Have you ever been treated for or told you might or low blood sugar? _____ _____ 
22.  Do you have any known allergies to drugs?    _____ _____ 
23.  If so, what?          
             
24.  Have you ever been ―knocked-out‖ or experienced a concussion? _____ _____ 
25.  If yes, have you been ―knocked-out‖ more than once?   _____ _____ 
26.  Have you ever experienced heat stroke or heat exhaustion?  _____ _____ 
27.  If yes, when?          
             
28.  Have you ever had any additional illnesses or operations? (Other than childhood 
diseases)         _____ _____ 
29.  If yes, please indicate specific illness or operations:     
             
30.  Are you now taking any pills or medications?    _____ _____ 
31.  If yes, please list:          
             
32.  Have you had any recent (within 1 year) difficulties with your: 
 a.  Feet        _____ _____ 
 b.  Legs        _____ _____ 
 c.  Back        _____ _____ 
 
 
Family History 
33.  Has anyone in your family (grandparent, father, mother, and/or sibling) experienced any 
of the following? 
 a.  Sudden death       _____ _____ 
 b.  Cardiac disease       _____ _____ 
 c.  Marfan‘s syndrome      _____ _____ 
 
Mental History 
34.  Have you ever experienced depression?     _____ _____ 
35.  If yes, did you seek the advice of a doctor?    _____ _____ 
36.  Have you ever been told you have or has a doctor diagnosed you with panic disorder, 
obsessive-compulsive disorder, clinical depression, bipolar disorder, or any other 
psychological disease?       _____ _____ 
37.  If yes, please list condition and if you are currently taking any medication. 
Condition      Medication 
            
            
             
Bone and Joint History 
34.  Have you ever been treated for Osgood-Schlatter‘s disease?  _____ _____ 
35.  Have you ever had any injury to your neck involving nerves or  
vertebrae?         _____ _____ 
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36.  Have you ever had a shoulder dislocation, separation, or other injury of the shoulder that 
incapacitated you for a week or longer?     _____ _____ 
37.  Have you ever been advised to or have you had surgery to correct a shoulder condition?
         _____ _____ 
38.  Have you ever experienced any injury to your arms, elbows, or wrists?_____ _____ 
39.  If yes, indicate location and type of injury:      
             
40.  Do you experience pain in your back?     _____ _____ 
41.  Have you ever had an injury to your back?    _____ _____ 
42.  If yes, did you seek the advice of a doctor?    _____ _____ 
43.  Have you ever been told that you injured the ligaments or cartilage of either knee joint?
          _____ _____ 
44.  Do you think you have a trick knee?     _____ _____ 
45.  Do you have a pin, screw, or plate somewhere in your body as the result of bone or joint 
surgery that presently limits your physical capacity?   _____ ____ 
46.  If yes, indicate where:         
             
47.  Have you ever had a bone graft or spinal fusion?   _____ _____ 
 
Activity History 
48.  During your early childhood (to age 12) would you say you were: 
 Very active ____ Quite active____ Moderately active____ Seldom active____ 
49.  During your adolescent years (age 13-18) would you say you were: 
 Very active ____ Quite active____ Moderately active____ Seldom active____ 
50.  Did you participate in: 
a. Intramural school sports?      _____ _____ 
b. Community sponsored sports?     _____ _____ 
c. Varsity school sports?      _____ _____ 
d. Active family recreation?      _____ _____ 
51.  Since leaving high school, how active have you been? 
 Very active ____ Quite active____  Active____  Inactive____ 
52.  Do you participate in any vigorous activity at present?   _____ _____ 
53.  If yes, please list: 
Activity  Frequency   Duration  Intensity 
            
            
            
             
54.  How would you describe your present state of fitness? 
Excellent_____ Good_____ Fair_____ Poor_____ 
55.  Please list the type(s) of work you have been doing for the previous ten years: 
Year  Work    Indoor/Outdoor Location (city/state) 
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56.  Whom shall we notify in case of emergency? 
 Name:            
 Phone: (Home)     (Work)     
 Address:           
57.  Name and address of personal physician:      
            
             
 
All of the above questions have been answered completely and truthfully to the best of my 
knowledge. 
 
Signature:        Date:     
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APPENDIX B 
 
PHYSICAL SCREENING 
 
Department of Exercise and Sport Science 
Physical Examination Screening 
 
Name: __________________________ Age: _______ Gender: ___________ 
 
Please respond to each of the following in writing. 
 
Pulse rate and regularity: _____________ ECG Interpretation: ___________________ 
 
Blood Pressure: 
Supine: ________ Sitting: ________ Standing (Left side): __________ 
Squat: _________ Standing (Right side): _________ 
 
Marfan Syndrome evaluation: (Δ BP, Physical Char.) ______________________ 
 
Palpation of Pulses: Carotid: _____ Radial: _____ Pedal: _____ 
 
Auscultation of the Lungs: 
Back: Lower: _____ Middle: _____ Upper: _____ 
Front: Middle: _____ Upper: _____ 
 
Auscultation of Heart Sounds (Supine, Standing, Squatting) 
Non-Specific HS: _____/_____/_____ 
Murmur: ____ Gallop: ____ Click: ____ Rub: ____ Click w/ Murmur: ____ 
 
Bruits: Carotid: _____ Abdominal: _____ 
 
Edema: Abdominal: _____ Calf: _____ Pedal: _____ 
 
Tenderness: Abdominal: _____ Other: _____ 
 
Xanthoma or xanthelasm: _____ 
 
Medical/Family History: 
High Blood Pressure: _____ Diabetes: _____ CHD/CAD: _____ 
 
Last examination w/ physician: __________ 
Medications (prescription/ counter): ____________________________________ 
 
 
Examiner: _____________________________________ Date: ___________________ 
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APPENDIX C 
 
Informed Consent 
 
University of North Carolina-Chapel Hill 
Consent to Participate in a Research Study 
Adult Participants 
Social Behavioral Form 
 
IRB Study #__ 09-1704__________________ 
Consent Form Version Date: 9/28/2009   
 
Title of Study: The Relationship between Plasma and Salivary Cortisol Levels in Response 
to Different Exercise Intensities 
 
Principal Investigator: Mitch D. VanBruggen 
UNC-Chapel Hill Department: Exercise and Sport Science (EXSS) 
UNC-Chapel Hill Phone number: 763-670-7878 
Email Address: vanbrugg@email.unc.edu  
 
Faculty Advisor:  Dr. Anthony C. Hackney  
Study Contact telephone number:  919-962-0334 
Study Contact email:  ach@email.unc.edu  
_________________________________________________________________ 
 
What are some general things you should know about research studies? 
You are being asked to take part in a research study.  To join the study is voluntary.  
You may refuse to join, or you may withdraw your consent to be in the study, for any reason, 
without penalty.  
 
Research studies are designed to obtain new knowledge. This new information may help 
people in the future.   You may not receive any direct benefit from being in the research 
study. There also may be risks to being in research studies. 
 
Details about this study are discussed below.  It is important that you understand this 
information so that you can make an informed choice about being in this research study.   
You will be given a copy of this consent form.  You should ask the researchers named above, 
or staff members who may assist them, any questions you have about this study at any time. 
 
What is the purpose of this study?  
The purpose of this research study is to learn about the relationship between blood and saliva 
cortisol levels at rest and in response to different exercise intensities to determine if salivary 
concentrations can be an accurate method to assess the body‘s stress response to exercise. 
  
You are being asked to be in the study because you are an endurance-trained male athlete.  
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Are there any reasons you should not be in this study? 
You should not be in this study if you do not exercise regularly; consume a diet chronically 
low in carbohydrates; have a prior history of hormonal disorders; have a mental illness; 
or engage in chronic non-steroidal anti-inflammatory (i.e. ibuprofen) drug use.  
 
How many people will take part in this study? 
If you decide to be in this study, you will be one of approximately twelve people in this 
research study. 
 
How long will your part in this study last?  
You will be asked to come to the Applied Physiology Laboratory (APL) in Fetzer 
Gymnasium for approximately 90-120 minutes on 5 separate occasions. These testing 
sessions will be separated by a minimum of 72 hours. More specific scheduling will be 
done after you agree to participate in the study, although each session will occur at the 
same time of day (within 30 minutes).  After your final exercise session, your 
participation in the study will be completed. 
 
What will happen if you take part in the study? 
You will be asked to report to the Applied Physiology Laboratory (APL) in Fetzer 
Gymnasium at the University of North Carolina-Chapel Hill on five separate occasions. 
You should maintain a consistent food intake throughout the duration of your 
participation. Also, you are asked to come to the laboratory having not exercised for 24 
hours, not eaten for the previous 4 hours, and having consumed no caffeine or alcohol for 
8 hours prior to the session. You must wear athletic clothing and shoes, or appropriate 
cycling gear to each exercise session.  A locker room will be provided should you need to 
change clothes. 
 
First visit to the laboratory: 
1. During the first visit, you will learn specific details about the study, read and sign the 
informed consent form, and have a brief discussion on dietary intake and training history. 
You will also complete a questionnaire to measure your stress levels. You will then 
undergo a familiarization process with the bike apparatus, blood and saliva collection 
procedures, and have your height, and body weight recorded.  You will also have your 
body fat percentage measured using skinfold calipers. 
2. Next, your blood pressure will be taken, and then you will have 10 electrodes placed on 
your chest in order to acquire a 12-lead resting electrocardiogram to determine if 
cardiovascular problems exist.  
3. If the ECG recording is normal, you will be properly fit with a mouthpiece (used to 
measure your respiratory gases), and a heart rate monitor.  A resting oxygen uptake will 
be assessed to make sure that the values are normal and the metabolic system is 
functioning properly. If everything is normal, you will be instructed to warm up on the 
bike for 5 minutes at a very light workload.  This light warm-up will be followed by 5 
minutes of stretching.  
4. After the warm-up, you will perform a bicycling graded exercise test, to determine your 
maximal aerobic capacity (VO2 max). During the test, your heart rate, respiratory gases, 
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and perceived exertion will be monitored continuously. The incremental exercise test will 
begin at a workload previously determined by your training history. The workload will 
increase at the end of 3 minute intervals (stages) until you feel you can no longer 
continue. 
5. After successful completion of the aerobic capacity test, you will cool down and be 
allowed to leave the laboratory after your heart rate is less than 100 beats per minute 
(bpm).  
6. Your initial visit to the laboratory will last approximately 90-120 minutes. 
 
Second, Third, Fourth, and Fifth Visits to the Laboratory: 
7. On a separate day, at least 72 hours but no more than approximately 7 days, following 
your previous visit, you will again report to the laboratory for either a resting session 
(control) or to perform your first 30 minute exercise session at one of the randomly 
selected intensities.  You will report to the laboratory for this test at the same time of day 
as your first visit (±30 minutes). During this testing session, you will have 3 blood draws 
performed and 3 saliva samples taken. All of the blood draws will be performed by a 
certified and experienced professional. The blood and saliva samples will be temporarily 
kept cool and then stored until the study is complete.  After completion of this study, all 
of the samples will be destroyed. 
8. First, you will rest in a supine (lying down, face-up) position (to control for posture) for 
30 minutes, after which the pre-exercise saliva and blood samples will be taken.  
Approximately 1 teaspoon (3cc) of blood and saliva will be collected with each 
respective sample (3 total samples during each exercise session). 
9. After the 30 minute resting period, the first blood and saliva sample will be taken.  Next, 
you will be asked to put on the heart rate monitor around your chest in order to measure 
your HR throughout the trial.  Finally, your resting heart rate and blood pressure will be 
taken. 
10. During each of the separate exercise trials, you will be asked to warm-up for 5 minutes 
on the bike and stretch.  You will then cycle at one of the randomly selected intensities, at 
approximately either 40%, 60%, or 80% of your maximal aerobic capacity. Your heart 
rate will be monitored every 5 minutes. You will also have wear the mouthpiece and 
nose-clip (as with the first session) to monitor your respiratory gases every 10 minutes. 
You will be able to drink water as needed. The duration of the exercise will be 30 
minutes.  
11. Immediately after exercise, a second blood and saliva sample will be collected. After the 
samples are collected, you will be allowed to actively cool down on the bike and then 
rest.  
12. Thirty minutes after the post-exercise blood and saliva samples are taken (Step 9 above), 
the final blood and saliva samples will be collected, after which you will be allowed to 
leave the laboratory.  
13. During the resting, control session, you will have 3 blood draws performed and 3 saliva 
samples taken, just as with the exercise sessions. However, instead of the exercise 
session, you will simply rest.  This session serves as a control. 
12. Each of these sessions should take approximately 90-120 minutes. 
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13. This process will be replicated for each of the sessions (40%, 60%, 80% intensity or 
control resting session), which will be separated by a minimum of 72 hours. 
 
What are the possible benefits from being in this study? 
 Research is designed to benefit society by gaining new knowledge.  
 You may also expect to benefit by participating in this study by receiving a free physical 
exam, and resting ECG.  You will also get to measure your aerobic capacity (maximal 
oxygen uptake) that can be used to aid you in any future training.   The study will also 
provide you with your ventilatory threshold, which can also be a tool to be used in 
training.  The serum and saliva cortisol values will also be made available to you after the 
study. 
 This study may help to provide a better understanding of associations between serum and 
salivary cortisol levels in response to exercise. Both athletes and researchers could 
benefit from this method‘s non-invasive, more feasible, and practical alternative to blood 
sampling if the relationship between these two methodologies are understood and can be 
properly applied to research design and methodology 
 
What are the possible risks or discomforts involved from being in this study? 
 There is a possibility that you will experience some light-headedness, dizziness, or 
fainting due to maximal and exhaustive exercise.  Additionally, there is a rare possibility 
that you will experience a heart attack or even death. However, due to your physically 
active status, the risk of catastrophic events is minimized. ECG and blood pressure 
measurements will be taken before tests to ensure proper heart functioning. The pre-
screening physical exam that includes basic measurements of pulmonary, circulatory, and 
orthopedic function will help detect any abnormalities that may result in termination of 
your participation in the study.  At least two individuals certified in CPR, AED, and first-
aid will be present during the entire test, and a proper emergency protocol is established 
if there is an emergency situation. 
 There is risk of bruising or infection with all blood draws.  These blood draws will be 
administered by an experienced professional, certified in phlebotomy. Proper first-aid 
procedures after the blood draws will also be followed in order to minimize infection and 
risk of bruising. 
 There is a likelihood that you will experience muscle soreness and general fatigue 
following exercise sessions.  This discomfort will be minimized allowing at least 72 
hours to pass in between sessions.  Also, a proper warm-up and stretch period prior to 
exercise bouts will help to minimize soreness.  No soreness that inhibits daily activities is 
likely to occur 
 There is also a rare possibility that any latent illness may become evident from the 
exercise or blood work.   
 There may be uncommon or previously unknown risks.  You should report any problems 
to the researcher. 
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How will your privacy be protected? 
 Every effort will be made to protect the confidentiality and privacy of the data obtained 
from you as a subject participating in the study in this study. You will assigned an ID 
number and all data entered into computer will not be identifiable by your name.  
 Only the principal investigator and the faculty advisor will have access to the names and 
the data of each of the subjects.   
 All information will be stored in locked file cabinets and secure password-protected, 
computer files.  
 In the event that the study is published, no association will be made between reported 
data and your name. 
You will not be identified in any report or publication about this study. Although every effort 
will be made to keep research records private, there may be times when federal or state law 
requires the disclosure of such records, including personal information.  This is very unlikely, 
but if disclosure is ever required, University of North Carolina at Chapel Hill will take steps 
allowable by law to protect the privacy of personal information.  In some cases, your 
information in this research study could be reviewed by representatives of the University, 
research sponsors, or government agencies for purposes such as quality control or safety. 
 
What will happen if you are injured by this research? 
All research involves a chance that something bad might happen to you.  This may include 
the risk of personal injury. In spite of all safety measures, you might develop a reaction or 
injury from being in this study. If such problems occur, the researchers will help you get 
medical care, but any costs for the medical care will be billed to you and/or your insurance 
company. The University of North Carolina at Chapel Hill has not set aside funds to pay you 
for any such reactions or injuries, or for the related medical care. However, by signing this 
form, you do not give up any of your legal rights. 
 
What if you want to stop before your part in the study is complete? 
You can withdraw from this study at any time, without penalty.  The investigators also have 
the right to stop your participation at any time. This could be because you have had an 
unexpected reaction, or have failed to follow instructions, or because the entire study has 
been stopped.  
 
Will you receive anything for being in this study? 
You will not receive anything for taking part in this study. 
 
What if you are a UNC student? 
You may choose not to be in the study or to stop being in the study before it is over at any 
time.  This will not affect your class standing or grades at UNC-Chapel Hill.  You will not be 
offered or receive any special consideration if you take part in this research. 
  
What if you are a UNC employee? 
Taking part in this research is not a part of your University duties, and refusing will not affect 
your job.  You will not be offered or receive any special job-related consideration if you take 
part in this research.   
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What if you have questions about this study? 
You have the right to ask, and have answered, any questions you may have about this 
research. If you have questions, complaints, concerns, or if a research-related injury occurs, 
you should contact the researchers listed on the first page of this form.  
 
What if you have questions about your rights as a research participant? 
All research on human volunteers is reviewed by a committee that works to protect your 
rights and welfare.  If you have questions or concerns about your rights as a research subject, 
or if you would like to obtain information or offer input, you may contact the Institutional 
Review Board at 919-966-3113 or by email to IRB_subjects@unc.edu. 
  
 
 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  
 
Title of Study: The Relationship Between Plasma and Salivary Cortisol Levels in Response 
to Different Exercise Intensities 
 
Principal Investigator: Mitch D. VanBruggen 
 
Participant’s Agreement:  
 
I have read the information provided above.  I have asked all the questions I have at this time.  
I voluntarily agree to participate in this research study. 
 
_________________________________________________ _________________ 
Signature of Research Participant  Date 
 
_________________________________________________ 
Printed Name of Research Participant 
 
 
_________________________________________________ _________________ 
Signature of Research Team Member Obtaining Consent  Date 
 
_________________________________________________ 
Printed Name of Research Team Member Obtaining Consent 
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APPENDIX D 
 
DATA COLLECTION SHEETS 
 
Orientation/VO2max Session 
 
Subject Name________________ Subject ID_____________________ 
  
Informed Consent 
1. Inform participant of the experimental protocol 
2. Make certain that the subject is aware of the possible risks 
3. Sign informed consent 
 
Participant Compliance Questions 
1.  Did subject refrain from strenuous physical activity for 24h prior to VO2 max testing? 
 Yes  No 
2.  Did the subject report to the lab 4 hours post-prandial? 
 Yes No 
3. Did the subject take NSAIDs, consume alcohol, or caffeine 8 hours prior to testing? 
 Yes  No 
 
Examinations _______ 
1. Medical History 
2. 12 Lead ECG 
3. Physical Examination 
 
Physical Characteristics 
1. Age _______ yrs 
2. Height _______ cm 
3. Mass _______ kg 
 
4. Percent Body Fat _______% 
 Skinfolds: 
 a. Chest (diagonal fold midway between upper armpit & nipple)  ______mm 
 b. Abdominal (vertical fold; 1 inch to right of navel)   ______mm 
 c. Thigh (vertical fold midway between kneecap and top of thigh)  ______mm  
   
Before VO2max Testing Protocol 
1. Set up metabolic system (gas calibration & mouthpiece) 
2. Fit electronically-braked cycle ergometer to the participant - record seat position using  
 Seat height: _______ cm 
3. Fit polar heart rate (HR) monitor to participant 
4. Make sure polar heart rate monitor picks up signal 
5. Place RPE scale near cycle ergometer/explain RPE to participant 
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Warm Up 
1. 5 minutes of cycling at light workload 
2. 5 minutes of stretching focused on the lower extremities 
3. Record resting oxygen consumption to verify values fall within normal range 
 
VO2 max Protocol  
1. Stage 1: 50W for 3 minutes:  HR _________; RPE _________ 
2. Stage 2: 100W for 3 minutes:  HR _________; RPE _________ 
3. Stage 3: 150W for 3 minutes:  HR _________; RPE _________ 
4. Stage 4: 200W for 3 minutes:  HR _________; RPE _________ 
5. Stage 5: 225W for 1 minute:  HR _________; RPE _________ 
6. Stage 6: 250W for 1 minute:  HR _________; RPE _________ 
7. Stage 7: 275W for 1 minute:  HR _________; RPE _________ 
8. Stage 8: 300W for 1 minute:  HR _________; RPE _________ 
9. Stage 9: 325W for 1 minute:  HR _________; RPE _________ 
10. Stage 10: 350W for 1 minute:  HR _________; RPE _________ 
11. Stage 11: 375W for 1 minute:  HR _________; RPE _________ 
12. Stage 12: 400W for 1 minute:  HR _________; RPE _________ 
 
13. Increase workload until volitional fatigue add more stages if necessary  
14. Recovery - reduce resistance and have participant continue pedaling 
15. Participant rests (supine) until HR is less than or equal to 100 bpm 
 
Was the total test time equal to or greater than 12 minutes? Test time = _________ 
 
Criteria for valid and reliable VO2 max Test  
1. Was there a 150 ml/min or less increase in oxygen consumption in response to an 
increased workload?  
Yes No 
2. Did the participant have a maximal RER equal to or greater than 1.1?  
RER =_________ 
3. Did the participant reach age-predicted maximal HR (220-age ± 5%)?  
HRmax =_________ 
4. Did the participant have a RPE equal to or greater than 18?  
RPE = _________ 
 
Recovery:   
1. Reduce resistance and have participant continue pedaling 
2. Allow subject to rest (supine) until HR is less than or equal to 100 bpm 
 
Before Subjects Leave Laboratory: 
1. Obtain diet 3-day diet record for analysis required before first experimental session 
2. Schedule first experimental session  
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Experimental Exercise Sessions 
 
Subject Name________________ Subject ID_____________________ 
 
Experimental sessions should start approximately one week after orientation/VO2max session; 
spaced 72 hours apart, randomized, and all completed at about (±30 min) the same time of 
day.  
 
 Administer REST-Q-Sport Questionnaire for Athletes to subject 
1. What was the subject‘s score? __________ 
 The score must be lower than 36 (average of the midpoints of each of the 12 
 scales; scale ranges from 1 to 6) for the subject to proceed on that day.  
 
Participant Compliance Questions 
1.  Did the subject refrain from strenuous physical activity for 24 hours prior to the 
experimental sessions? 
 Yes  No 
2.  Did the subject report to the lab 4 hours post-prandial? 
 Yes No 
3. Did the subject take NSAIDs, consume alcohol, or caffeine 8 hours prior to testing?
 Yes  No 
  
Before Starting Exercise Protocols  
1. Set up metabolic system (calibrate, mouthpiece, etc)  
2. Set up blood collection supplies 
3. Set up saliva collection supplies 
4. Set up cycle ergometer to previously recorded seat height: ________ cm 
5. Fit polar heart rate (HR) monitor to participant 
6. Make sure polar heart rate monitor picks up signal 
7. Place RPE scale near cycle ergometer 
 
Pre-Exercise Rest 
1. The participant will rest in the supine position for 30 minutes 
2. While subject is resting, place catheter into arm. 
3. After 30 minutes rest, obtain 3-mL of venous blood 
4. Place blood into a sterile K
2
 EDTA (purple top) Vacutainer® tube; place tube on ice 
5. Obtain resting saliva sample (~0.5-1.0 mL); place saliva in polypropylene vial 
  If subject has trouble salivating, stimulate through chewing on paraffin film  
 
Warm Up 
1. 5 minutes of cycling at light workload (~15-20% VO2 max) 
2. 5 minutes of stretching focused on the lower extremities 
3. Record resting oxygen consumption to verify values fall within normal range 
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Exercise Protocol 
Randomly Assigned Exercise Intensity and Corresponding Workload 
 
____40% VO2 max Workload_______W 
____60% VO2 max  Workload_______W  
____80% VO2 max Workload_______W 
 
During exercise, subjects are allowed to consumer water ad-libitum 
 
Cycle for 30 minutes at the previously determined workload. 
Minute 0: HR _________ RPE _________ 
Minute 5:  HR _________ RPE _________ 
Minute 7-10 VO2 measurement (remove mouthpiece after sampling) 
Minute 10: HR _________  RPE _________ 
Minute 15:  HR _________  RPE _________ 
Minute 17-20 VO2 measurement (remove mouthpiece after sampling) 
Minute 20: HR _________  RPE _________ 
Minute 25:  HR _________  RPE _________ 
Minute 27-30: VO2 measurement (remove mouthpiece after sampling) 
Minute 30: HR _________  RPE _________ 
 
 
Immediately Post-Exercise 
1. Immediately after 30 minute exercise session, obtain 3-mL of venous blood. 
2. Place blood into a sterile K
2
 EDTA (purple top) Vacutainer® tube; place tube on ice 
3. Obtain saliva sample (~0.5-1.0 mL); place saliva in polypropylene vial 
  If subject has trouble salivating, stimulate through chewing on paraffin film  
4. Begin supine resting session 
 
Resting/Recovery 
1. Immediately after 30 minute supine recovery session, obtain 3-mL of venous blood. 
2. Place blood into a sterile K
2
 EDTA (purple top) Vacutainer® tube; place tube on ice 
3. Obtain saliva sample (~0.5-1.0 mL); place saliva in polypropylene vial 
  If subject has trouble salivating, stimulate through chewing on paraffin film  
 
Before Subjects Leave Laboratory: 
1. Make sure heart rate is below 100 bpm 
2. Schedule next experimental session 
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Experimental Control (Resting) Session 
 
Subject Name________________ Subject ID_____________________ 
 
Control/Resting session will be randomly assigned and may occur at any point in the timeline 
of the 4 separate experimental sessions.  As with the exercise sessions, this session should be 
spaced 72 hours apart from other sessions and all completed at the same time of day (±30 
min) as the other sessions  
 
 Administer REST-Q-Sport Questionnaire for Athletes to subject 
1. What was the subject‘s score? __________ 
 The score must be lower than 36 (average of the midpoints of each of the 12 
 scales; scale ranges from 1 to 6) for the subject to proceed on that day.  
 
Before Starting Control Session  
1. Set up blood collection supplies 
2. Set up saliva collection supplies 
 
Pre-Rest Procedures 
1. The participant will rest in the supine position for 30 minutes 
2. While subject is resting, place catheter into arm. 
3. After 30 minutes rest, obtain 3-mL of venous blood 
4. Place blood into a sterile K
2
 EDTA (purple top) Vacutainer® tube; place tube on ice 
5. Obtain resting saliva sample (~0.5-1.0 mL); place saliva in polypropylene vial 
  If subject has trouble salivating, stimulate through chewing on paraffin film  
 
Resting Protocol 
Instead of exercise, subject will rest in supine position for 30 minutes 
 
Immediately Post-Rest 
1. Immediately after 30 minute resting/control session, obtain 3-mL of venous blood. 
2. Place blood into a sterile K
2
 EDTA (purple top) Vacutainer® tube; place tube on ice 
3. Obtain saliva sample (~0.5-1.0 mL); place saliva in polypropylene vial 
  If subject has trouble salivating, stimulate through chewing on paraffin film  
4. Begin supine resting position 
 
Post-Rest Procedures 
1. Immediately after 30 minute supine resting session, obtain 3-mL of venous blood. 
2. Place blood into a sterile K
2
 EDTA (purple top) Vacutainer® tube; place tube on ice 
3. Obtain saliva sample (~0.5-1.0 mL); place saliva in polypropylene vial 
  If subject has trouble salivating, stimulate through chewing on paraffin film  
 
Before Subjects Leave Laboratory: 
1.  Schedule next experimental session 
 
67 
 
APPENDIX E 
 
ASSAY INFORMATION 
 
Serum Cortisol Assay Procedures 
 
All components must be at room temperature (15-28º C) before use. 
 
1.  Plain Tubes: Label four plain (uncoated) 12 x 75 mm polypropylene tubes T (total 
 counts) and NSB (non-specific binding) in duplicate. Because non-specific binding in 
 the Coat-A-Count procedure is low, the NSB tubes can be omitted without  
 compromising accuracy or quality control. 
 Coated Tubes: Label twelve Cortisol Ab-Coated Tubes A (maximum binding) and B 
 through F in duplicate. Label additional Cortisol Ab-Coated Tubes, in duplicate, for 
 controls and patient samples. 
 
 Calibrators     μg/dL      nmol/L 
 A (MB)     0      0 
 B      1      27.6 
 C      5      138 
 D     10      276 
 E      20      552 
 F     50      1380 
 
2. Pipet 25 μL of the zero calibrator A into the NSB and A tubes. Pipet 25 μL of each 
 remaining calibrator, control, and patient samples into the tubes prepared. Pipet 
 directly to the bottom. It is good practice to use a disposable-tip micropipette, 
 changing the tip between samples, in order to avoid carryover contamination. 
 
3.  Add 1.0 mL of 125I Cortisol into every tube. Vortex. Laboratories equipped with a 
 reliable pipettor-diluter may handle steps 2 and 3 simultaneously. No more than 10 
 minutes should elapse during the dispensing of the tracer. Set the T tubes aside for 
 counting at step 6; they require no further processing. 
 
4.  Incubate for 45 minutes at 37º C. Use a water bath; neither an oven nor a heat block is 
 suitable. Longer incubation periods will not significantly affect the assay. 
 
5.  Decant thoroughly. Removing all visible moisture will greatly enhance precision. 
 Decant the contents of all tubes (except the T tubes) using a foam decanting rack, and 
 allow them to drain for 2 or 3 minutes. Then strike the tubes sharply on absorbent  
 paper to shake off all residual droplets. 
 
6.  Count for 1 minute in a gamma counter. 
68 
 
Salivary Cortisol Assay Procedures  
 
1.  Bring all reagents to room temperature and mix before use.  
 
2.  Prepare 1X wash buffer (and reconstitute stop solution, if appropriate).  
 
3.  Bring plate to room temperature and prepare for use with NSB wells.  
 
4.  Prepare tube with 24 mL of assay diluent for conjugate dilution, which will be made 
 later.  
 
5.  Pipette 25 μL of standards, controls, and unknowns into appropriate wells.  
 
6.  Pipette 25 μL of assay diluent into zero and NSB wells.  
 
7.  Make final 1:1600 dilution of conjugate (15 μL into 24 mL assay diluent), mix, and 
 immediately pipette 200 μL into each well.  
 
8.  Mix plate for 5 minutes at 500 rpm. Incubate for an additional 55 minutes at room 
 temperature.  
 
9.  Wash plate 4 times with 1X wash buffer. Blot.  
 
10.  Add 200 μL TMB solution to each well.  
 
11.  Mix plate for 5 minutes at 500 rpm. Incubate in dark at room temperature for 25 
 additional minutes.  
 
12.  Add 50 μL stop solution to each well. Mix for 3 minutes at 500 rpm.  
 
13.  Wipe plate bottom clean and read within 10 minutes of adding stop. 
 
  
  Calculations  
 
 1. Compute the average optical density (OD) for all duplicate wells.  
 
 2. Subtract the average OD for the NSB wells from the average OD of the zero, 
 standards, controls, and unknowns.  
 
 3. Calculate the percent bound (B/Bo) for each standard, control, and unknown by 
 dividing the average OD (B) by the average OD for the zero (Bo).  
 
        4. Determine the concentrations of the controls and unknowns by interpolation.
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